Cancer-causing Chemical Found in Walgreens Disney Animal Crackers

| April 11, 2017

article image
CEH has launched legal action against Walgreens and other companies for failing to warn consumers about the high levels of acrylamide in their products. Acrylamide in food has been a serious concern since 2002 when scientists discovered the cancer-causing chemical in many common products. The chemical poses particular threats to young children: given their smaller size and the types of foods they consume, they typically take in twice as much acrylamide, per pound of body weight, as adults. In pregnant women, higher levels of dietary acrylamide have been linked to reduced birth weight and head circumference, key indicators of a child’s future health.

Spotlight

Pacira Pharmaceuticals, Inc.

Pacira Pharmaceuticals, Inc. is an emerging specialty pharmaceutical company focused on the clinical and commercial development of new products that meet the needs of acute care practitioners and their patients. The company's current emphasis is the development of non-opioid products for postsurgical pain control, and its lead product, EXPAREL® (bupivacaine liposome injectable suspension), was commercially launched in the United States in April 2012. EXPAREL and two other products have utilized the Pacira proprietary product delivery technology DepoFoam®, a unique platform that encapsulates drugs without altering their molecular structure and then releases them over a desired period of time.

OTHER ARTICLES

Chemical Accidents Lead To Increase In Investigations

Article | February 17, 2020

In the last two years, the U.S. Chemical Safety Board (CSB) has launched investigations into seven separate chemical accidents or explosions in the Houston area. Prior to 2018, the CSB only conducted roughly one investigation per year. Investigators believe that the massive increase in accidents which require an investigation by the CSB is due to a variety of factors such as the large number of chemical companies in the Houston area, the age of the infrastructure, and companies being allowed to self-regulate. Many of these explosions and fires have directly led to the deaths of workers, bystanders, millions of dollars in property damage, and the evacuation of tens of thousands of local residents who risk being exposed to toxic chemicals.

Read More

NON-CHEMICAL WEED CONTROL WITH FOAMSTREAM

Article | February 21, 2020

Unwanted weeds and vegetation don’t have to be controlled with harmful and dangerous chemicals. There are plenty of non-chemical and organic methods of weed control that are reliable and safe to use, such as Foamstream. Non-chemical weed control is the process of killing weeds without harmful toxins. This is sometimes referred to as cultural or organic weed control, with methods ranging from hoeing and hand-pulling, to hot water and of course, Foamstream.

Read More

How Is the SCIP Database Different From the REACH Regulation

Article | February 14, 2020

Companies operating in the European Union (EU) must submit data when introducing articles containing Substances of Very High Concern (SVHCs) above the 0.1 percent weight by weight (w/w) threshold. The reporting trigger for an in-scope article is currently derived from the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) Regulation’s Candidate List of SVHCs, but the data requirements for the SCIP database, triggered by the EU Waste Framework Directive (WFD), vary widely from those required by the REACH Regulation.

Read More

Taiwan Amends the Toxic Chemical Substance Operators Liability Insurance Measures

Article | March 1, 2020

Taiwan amended the Toxic Chemical Substances Operation Liability Insurance Measures and renamed it the Toxic and Concerned Chemical Substance Operators Liability Insurance Measures. The Measures require operators to obtain liability insurance before operation if the total amount during the manufacture, use, storage, and transportation of toxic chemicals of the first to third categories or hazardous chemical substances of concern reach a specified benchmark.

Read More

Spotlight

Pacira Pharmaceuticals, Inc.

Pacira Pharmaceuticals, Inc. is an emerging specialty pharmaceutical company focused on the clinical and commercial development of new products that meet the needs of acute care practitioners and their patients. The company's current emphasis is the development of non-opioid products for postsurgical pain control, and its lead product, EXPAREL® (bupivacaine liposome injectable suspension), was commercially launched in the United States in April 2012. EXPAREL and two other products have utilized the Pacira proprietary product delivery technology DepoFoam®, a unique platform that encapsulates drugs without altering their molecular structure and then releases them over a desired period of time.

Events